145 related articles for article (PubMed ID: 20659095)
1. Solid organ transplantation after allogeneic hematopoietic stem cell transplantation: a retrospective, multicenter study of the EBMT.
Koenecke C; Hertenstein B; Schetelig J; van Biezen A; Dammann E; Gratwohl A; Ganser A; Schleuning M; Bornhäuser M; Jacobsen N; Kröger N; Niederwieser D; de Witte T; Ruutu T
Am J Transplant; 2010 Aug; 10(8):1897-906. PubMed ID: 20659095
[TBL] [Abstract][Full Text] [Related]
2. Solid organ transplantation after hematopoietic stem cell transplantation in childhood: A multicentric retrospective survey.
Faraci M; Bertaina A; Dalissier A; Ifversen M; Schulz A; Gennery A; Burkhardt B; Badell Serra I; Diaz-de-Heredia C; Lanino E; Lankester AC; Gruhn B; Matthes-Martin S; Kühl JS; Varotto S; Paillard C; Guilmatre A; Sastre A; Abecasis M; Garwer B; Sedlacek P; Boelens JJ; Beohou E; Bader P;
Am J Transplant; 2019 Jun; 19(6):1798-1805. PubMed ID: 30586230
[TBL] [Abstract][Full Text] [Related]
3. Hematopoietic Stem Cell Transplantation in Solid Organ Recipients with Emphasis on Transplant Complications: A Nationwide Retrospective Survey on Behalf of the Japan Society for Hematopoietic Stem Cell Transplantation Transplant Complications Working Group.
Shinohara A; Oshima K; Fuji S; Umeda K; Kako S; Kurokawa M; Tsukada N; Kasai M; Kondo T; Hashii Y; Nakamae H; Ikegame K; Kosaka Y; Shimada A; Nawa Y; Makoto Y; Yoshiko A; Fukuda T; Tanaka J; Ogata M
Biol Blood Marrow Transplant; 2020 Jan; 26(1):66-75. PubMed ID: 31494230
[TBL] [Abstract][Full Text] [Related]
4. Allogeneic hematopoietic stem cell transplantation in solid organ transplant recipients: a retrospective, multicenter study of the EBMT.
Basak GW; Wiktor-Jedrzejczak W; Labopin M; Schoemans H; Ljungman P; Kobbe G; Beguin Y; Lang P; Koenecke C; Sykora KW; Te Boome L; van Biezen A; van der Werf S; Mohty M; de Witte T; Marsh J; Dreger P; Kröger N; Duarte R; Ruutu T
Am J Transplant; 2015 Mar; 15(3):705-14. PubMed ID: 25648262
[TBL] [Abstract][Full Text] [Related]
5. Risk of Subsequent Vitiligo in Transplant Recipients With Comorbid Graft-vs-Host Disease.
Bang CH; Park HE; Kim YH; Jung JH; Lee JH; Park YM; Han JH
JAMA Dermatol; 2024 Feb; 160(2):194-198. PubMed ID: 38091023
[TBL] [Abstract][Full Text] [Related]
6. Post-transplant lymphoproliferative disorders after solid organ and hematopoietic stem cell transplantation.
Romero S; Montoro J; Guinot M; Almenar L; Andreu R; Balaguer A; Beneyto I; Espí J; Gómez-Codina J; Iacoboni G; Jarque I; López-Andújar R; Mayordomo-Aranda E; Montalar J; Pastor A; Pastor M; Piñana JL; Rojas-Ferrer N; Sánchez-Lázaro I; Sandoval J; Sanz G; Sanz MÁ; Solé A; Sanz J
Leuk Lymphoma; 2019 Jan; 60(1):142-150. PubMed ID: 29966464
[TBL] [Abstract][Full Text] [Related]
7. Hematopoietic Cell and Solid Organ Transplantation in the Same Patient: Long-Term Experience at the University of Minnesota.
El Jurdi N; DeFor T; Adamusiak AM; Brunstein CG; Pruett T; Weisdorf DJ
Transplant Cell Ther; 2021 Jan; 27(1):87.e1-87.e6. PubMed ID: 32949755
[TBL] [Abstract][Full Text] [Related]
8. Impact of Donor Epstein-Barr Virus Serostatus on the Incidence of Graft-Versus-Host Disease in Patients With Acute Leukemia After Hematopoietic Stem-Cell Transplantation: A Study From the Acute Leukemia and Infectious Diseases Working Parties of the European Society for Blood and Marrow Transplantation.
Styczynski J; Tridello G; Gil L; Ljungman P; Hoek J; Iacobelli S; Ward KN; Cordonnier C; Einsele H; Socie G; Milpied N; Veelken H; Chevallier P; Yakoub-Agha I; Maertens J; Blaise D; Cornelissen J; Michallet M; Daguindau E; Petersen E; Passweg J; Greinix H; Duarte RF; Kröger N; Dreger P; Mohty M; Nagler A; Cesaro S
J Clin Oncol; 2016 Jul; 34(19):2212-20. PubMed ID: 27091716
[TBL] [Abstract][Full Text] [Related]
9. Histopathologic and immunophenotypic features of cutaneous solid organ transplant-associated graft-vs-host disease: Comparison with acute hematopoietic cell transplant-associated graft-vs-host disease and cutaneous drug eruption.
Russell AJ; Musiek AC; Staser KW; Rosman IS
J Cutan Pathol; 2021 Dec; 48(12):1480-1488. PubMed ID: 34173980
[TBL] [Abstract][Full Text] [Related]
10. Incidence of invasive aspergillosis following hematopoietic stem cell and solid organ transplantation: interim results of a prospective multicenter surveillance program.
Morgan J; Wannemuehler KA; Marr KA; Hadley S; Kontoyiannis DP; Walsh TJ; Fridkin SK; Pappas PG; Warnock DW
Med Mycol; 2005 May; 43 Suppl 1():S49-58. PubMed ID: 16110792
[TBL] [Abstract][Full Text] [Related]
11. Hematopoietic Cell Transplantation after Solid Organ Transplantation.
Doney KC; Mielcarek M; Stewart FM; Appelbaum FR
Biol Blood Marrow Transplant; 2015 Dec; 21(12):2123-2128. PubMed ID: 26271193
[TBL] [Abstract][Full Text] [Related]
12. Early Clostridioides difficile infection characterizations, risks, and outcomes in allogeneic hematopoietic stem cell and solid organ transplant recipients.
Obeid KM; Sapkota S; Cao Q; Richmond S; Watson AP; Karadag FK; Young JH; Pruett T; Weisdorf DJ; Ustun C
Transpl Infect Dis; 2022 Feb; 24(1):e13720. PubMed ID: 34455662
[TBL] [Abstract][Full Text] [Related]
13. Bacterial infections in pediatric hematopoietic stem cell transplantation recipients: incidence, epidemiology, and spectrum of pathogens: report of the Polish Pediatric Group for Hematopoietic Stem Cell Transplantation.
Zając-Spychała O; Wachowiak J; Pieczonka A; Siewiera K; Frączkiewicz J; Kałwak K; Gorczyńska E; Chybicka A; Czyżewski K; Jachna-Sawicka K; Wysocki M; Klepacka J; Goździk J; Zaucha-Prażmo A; Kowalczyk JR; Styczyński J
Transpl Infect Dis; 2016 Oct; 18(5):690-698. PubMed ID: 27479544
[TBL] [Abstract][Full Text] [Related]
14. Epidemiology, outcomes, and mortality predictors of invasive mold infections among transplant recipients: a 10-year, single-center experience.
Neofytos D; Treadway S; Ostrander D; Alonso CD; Dierberg KL; Nussenblatt V; Durand CM; Thompson CB; Marr KA
Transpl Infect Dis; 2013 Jun; 15(3):233-42. PubMed ID: 23432974
[TBL] [Abstract][Full Text] [Related]
15. Solid organ transplants following hematopoietic stem cell transplant in children.
Bunin N; Guzikowski V; Rand ER; Goldfarb S; Baluarte J; Meyers K; Olthoff KM
Pediatr Transplant; 2010 Dec; 14(8):1030-5. PubMed ID: 20846242
[TBL] [Abstract][Full Text] [Related]
16. The importance of graft cell composition in outcome after allogeneic stem cell transplantation in patients with malignant disease.
Svenberg P; Wang T; Uhlin M; Watz E; Remberger M; Ringden O; Mattsson J; Uzunel M
Clin Transplant; 2019 Jun; 33(6):e13537. PubMed ID: 30873642
[TBL] [Abstract][Full Text] [Related]
17. Predictive Factors and Outcomes after Allogeneic Stem Cell Transplantation for Adults with Acute Lymphoblastic Leukemia in Brazil.
Silva WF; Cysne DN; Kerbauy MN; Colturato I; Maia ACA; Tucunduva L; Barros GMN; Colturato VAR; Hamerschlak N; Rocha V
Transplant Cell Ther; 2022 Nov; 28(11):763.e1-763.e7. PubMed ID: 35914726
[TBL] [Abstract][Full Text] [Related]
18. Allogeneic HSCT for Autoimmune Diseases: A Retrospective Study From the EBMT ADWP, IEWP, and PDWP Working Parties.
Greco R; Labopin M; Badoglio M; Veys P; Furtado Silva JM; Abinun M; Gualandi F; Bornhauser M; Ciceri F; Saccardi R; Lankester A; Alexander T; Gennery AR; Bader P; Farge D; Snowden JA
Front Immunol; 2019; 10():1570. PubMed ID: 31333680
[No Abstract] [Full Text] [Related]
19. Cancer incidence in immunocompromised patients: a single-center cohort study.
Ilham S; Willis C; Kim K; Chung KC; Wood BM; Tan MS; Tan CJ; Nguyen DT; Brixner DI; Stenehjem DD
BMC Cancer; 2023 Jan; 23(1):33. PubMed ID: 36624408
[TBL] [Abstract][Full Text] [Related]
20. Impact of graft-versus-host disease on the clinical outcome of allogeneic hematopoietic stem cell transplantation for non-malignant diseases.
Umeda K; Imai K; Yanagimachi M; Yabe H; Kobayashi M; Takahashi Y; Kajiwara M; Yoshida N; Cho Y; Inoue M; Hashii Y; Atsuta Y; Morio T;
Int J Hematol; 2020 Jun; 111(6):869-876. PubMed ID: 32052319
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
